Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16890769 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Trial of the ALK Grass Tablet in Subjects With Hayfever
Condition: Allergy
Intervention: Biological: ALK Grass tablet

Indicates status has not been verified in more than two years